Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 127

1.

Clinical requirements for closed-loop control systems.

Clarke WL, Renard E.

J Diabetes Sci Technol. 2012 Mar 1;6(2):444-52. Review.

2.

An integrated multivariable artificial pancreas control system.

Turksoy K, Quinn LT, Littlejohn E, Cinar A.

J Diabetes Sci Technol. 2014 May;8(3):498-507. doi: 10.1177/1932296814524862. Epub 2014 Apr 7.

3.

Closed-loop artificial pancreas using subcutaneous glucose sensing and insulin delivery and a model predictive control algorithm: preliminary studies in Padova and Montpellier.

Bruttomesso D, Farret A, Costa S, Marescotti MC, Vettore M, Avogaro A, Tiengo A, Dalla Man C, Place J, Facchinetti A, Guerra S, Magni L, De Nicolao G, Cobelli C, Renard E, Maran A.

J Diabetes Sci Technol. 2009 Sep 1;3(5):1014-21.

4.

Bolus calculator improves long-term metabolic control and reduces glucose variability in pump-treated patients with Type 1 diabetes.

Lepore G, Dodesini AR, Nosari I, Scaranna C, Corsi A, Trevisan R.

Nutr Metab Cardiovasc Dis. 2012 Aug;22(8):e15-6. doi: 10.1016/j.numecd.2012.04.001. Epub 2012 Jun 4. No abstract available.

PMID:
22673770
5.

Automatic data processing to achieve a safe telemedical artificial pancreas.

Hernando ME, García-Sáez G, Martínez-Sarriegui I, Rodríguez-Herrero A, Pérez-Gandía C, Rigla M, de Leiva A, Capel I, Pons B, Gómez EJ.

J Diabetes Sci Technol. 2009 Sep 1;3(5):1039-46.

6.

Closed-loop artificial pancreas using subcutaneous glucose sensing and insulin delivery and a model predictive control algorithm: the Virginia experience.

Clarke WL, Anderson S, Breton M, Patek S, Kashmer L, Kovatchev B.

J Diabetes Sci Technol. 2009 Sep 1;3(5):1031-8.

7.

Overnight closed-loop insulin delivery with model predictive control: assessment of hypoglycemia and hyperglycemia risk using simulation studies.

Wilinska ME, Budiman ES, Taub MB, Elleri D, Allen JM, Acerini CL, Dunger DB, Hovorka R.

J Diabetes Sci Technol. 2009 Sep 1;3(5):1109-20.

8.

Factors Associated With Glycemic Control During Free-Living Overnight Closed-Loop Insulin Delivery in Children and Adults With Type 1 Diabetes.

Tauschmann M, Thabit H, Leelarathna L, Elleri D, Allen JM, Lubina-Solomon A, Stadler M, Walkinshaw E, Iqbal A, Choudhary P, Wilinska ME, Heller SR, Amiel SA, Evans ML, Dunger DB, Hovorka R.

J Diabetes Sci Technol. 2015 Oct 7;9(6):1346-7. doi: 10.1177/1932296815604439. No abstract available.

9.

Multinational study of subcutaneous model-predictive closed-loop control in type 1 diabetes mellitus: summary of the results.

Kovatchev B, Cobelli C, Renard E, Anderson S, Breton M, Patek S, Clarke W, Bruttomesso D, Maran A, Costa S, Avogaro A, Dalla Man C, Facchinetti A, Magni L, De Nicolao G, Place J, Farret A.

J Diabetes Sci Technol. 2010 Nov 1;4(6):1374-81.

10.

Control to range for diabetes: functionality and modular architecture.

Kovatchev B, Patek S, Dassau E, Doyle FJ 3rd, Magni L, De Nicolao G, Cobelli C; Juvenile Diabetes Research Foundation Artificial Pancreas Consortium..

J Diabetes Sci Technol. 2009 Sep 1;3(5):1058-65.

11.

Accuracy of Continuous Glucose Monitoring During Three Closed-Loop Home Studies Under Free-Living Conditions.

Thabit H, Leelarathna L, Wilinska ME, Elleri D, Allen JM, Lubina-Solomon A, Walkinshaw E, Stadler M, Choudhary P, Mader JK, Dellweg S, Benesch C, Pieber TR, Arnolds S, Heller SR, Amiel SA, Dunger D, Evans ML, Hovorka R.

Diabetes Technol Ther. 2015 Nov;17(11):801-7. doi: 10.1089/dia.2015.0062. Epub 2015 Aug 4.

12.

Threshold-based insulin-pump interruption for reduction of hypoglycemia.

Bergenstal RM, Klonoff DC, Garg SK, Bode BW, Meredith M, Slover RH, Ahmann AJ, Welsh JB, Lee SW, Kaufman FR; ASPIRE In-Home Study Group..

N Engl J Med. 2013 Jul 18;369(3):224-32. doi: 10.1056/NEJMoa1303576. Epub 2013 Jun 22.

13.

Unsupervised home use of an overnight closed-loop system over 3-4 weeks: a pooled analysis of randomized controlled studies in adults and adolescents with type 1 diabetes.

Thabit H, Elleri D, Leelarathna L, Allen JM, Lubina-Solomon A, Stadler M, Walkinshaw E, Iqbal A, Choudhary P, Wilinska ME, Barnard KD, Heller SR, Amiel SA, Evans ML, Dunger DB, Hovorka R.

Diabetes Obes Metab. 2015 May;17(5):452-8. doi: 10.1111/dom.12427. Epub 2015 Jan 9.

14.

Multicenter user evaluation of ACCU-CHEK® Combo, an integrated system for continuous subcutaneous insulin infusion.

Kerr D, Hoogma RP, Buhr A, Petersen B, Storms FE; study investigators..

J Diabetes Sci Technol. 2010 Nov 1;4(6):1400-7.

15.

The impact of continuous glucose monitoring on low interstitial glucose values and low blood glucose values assessed by point-of-care blood glucose meters: results of a crossover trial.

Hermanns N, Schumann B, Kulzer B, Haak T.

J Diabetes Sci Technol. 2014 May;8(3):516-22. doi: 10.1177/1932296814524105. Epub 2014 Feb 21.

16.

User acceptability and perceived benefits of new reports in CareLink Pro 3.0 Therapy Management Software for Diabetes.

Welsh JB, Myers SJ, Uhrinak AN, Kaufman FR, Lee SW.

J Diabetes Sci Technol. 2012 Mar 1;6(2):481-2. No abstract available.

18.

Continuous glucose monitors: use of waveform versus glycemic values in the improvements of glucose control, quality of life, and fear of hypoglycemia.

Walker TC, Yucha CB.

J Diabetes Sci Technol. 2014 May;8(3):488-93. doi: 10.1177/1932296814528434. Epub 2014 Mar 22.

19.

Analysis: high-tech diabetes technology and the myth of clinical "plug and play".

Weinzimer SA.

J Diabetes Sci Technol. 2010 Nov 1;4(6):1465-7.

Supplemental Content

Support Center